These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 3233711)

  • 1. A biophysical mechanism by which plasma proteins inhibit lung surfactant activity.
    Holm BA; Enhorning G; Notter RH
    Chem Phys Lipids; 1988 Nov; 49(1-2):49-55. PubMed ID: 3233711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple mechanisms of lung surfactant inhibition.
    Holm BA; Wang Z; Notter RH
    Pediatr Res; 1999 Jul; 46(1):85-93. PubMed ID: 10400140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations.
    Seeger W; Grube C; Günther A; Schmidt R
    Eur Respir J; 1993 Jul; 6(7):971-7. PubMed ID: 8370446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surface properties and sensitivity to protein-inhibition of a recombinant apoprotein C-based phospholipid mixture in vitro--comparison to natural surfactant.
    Seeger W; Thede C; Günther A; Grube C
    Biochim Biophys Acta; 1991 Jan; 1081(1):45-52. PubMed ID: 1991155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of different hydrophobic constituents in the adsorption of pulmonary surfactant.
    Wang Z; Hall SB; Notter RH
    J Lipid Res; 1996 Apr; 37(4):790-8. PubMed ID: 8732779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of hemoglobin and cell membrane lipids on pulmonary surfactant activity.
    Holm BA; Notter RH
    J Appl Physiol (1985); 1987 Oct; 63(4):1434-42. PubMed ID: 3693177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung surfactant phospholipids associate with polymerizing fibrin: loss of surface activity.
    Seeger W; Elssner A; Günther A; Krämer HJ; Kalinowski HO
    Am J Respir Cell Mol Biol; 1993 Aug; 9(2):213-20. PubMed ID: 8338688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary importance of zwitterionic over anionic phospholipids in the surface-active function of calf lung surfactant extract.
    Wang Z; Gurel O; Weinbach S; Notter RH
    Am J Respir Crit Care Med; 1997 Oct; 156(4 Pt 1):1049-57. PubMed ID: 9351602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thermodynamic effects of the hydrophobic surfactant proteins on the early adsorption of pulmonary surfactant.
    Schram V; Hall SB
    Biophys J; 2001 Sep; 81(3):1536-46. PubMed ID: 11509366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biophysical inhibition of synthetic lung surfactants.
    Holm BA; Venkitaraman AR; Enhorning G; Notter RH
    Chem Phys Lipids; 1990 Feb; 52(3-4):243-50. PubMed ID: 2340601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of biophysical activity of lung surfactant extracts and phospholipid-apoprotein mixtures by surfactant protein A.
    Venkitaraman AR; Hall SB; Whitsett JA; Notter RH
    Chem Phys Lipids; 1990 Dec; 56(2-3):185-94. PubMed ID: 2095991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-cooperative effects of lung surfactant proteins on early adsorption to an air/water interface.
    Schram V; Anyan WR; Hall SB
    Biochim Biophys Acta; 2003 Oct; 1616(2):165-73. PubMed ID: 14561474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surface activity of a synthetic lung surfactant containing a phospholipase-resistant phosphonolipid analog of dipalmitoyl phosphatidylcholine.
    Wang Z; Schwan AL; Lairson LL; O'Donnell JS; Byrne GF; Foye A; Holm BA; Notter RH
    Am J Physiol Lung Cell Mol Physiol; 2003 Sep; 285(3):L550-9. PubMed ID: 12902318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Content of dipalmitoyl phosphatidylcholine in lung surfactant: ramifications for surface activity.
    Holm BA; Wang Z; Egan EA; Notter RH
    Pediatr Res; 1996 May; 39(5):805-11. PubMed ID: 8726232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biophysical activity of synthetic phospholipids combined with purified lung surfactant 6000 dalton apoprotein.
    Notter RH; Shapiro DL; Ohning B; Whitsett JA
    Chem Phys Lipids; 1987 Jun; 44(1):1-17. PubMed ID: 3607971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of mechanisms of surfactant inhibition.
    Gunasekara L; Schoel WM; Schürch S; Amrein MW
    Biochim Biophys Acta; 2008 Feb; 1778(2):433-44. PubMed ID: 18036553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral cell wall lipids of Mycobacterium tuberculosis are inhibitory to surfactant function.
    Wang Z; Schwab U; Rhoades E; Chess PR; Russell DG; Notter RH
    Tuberculosis (Edinb); 2008 May; 88(3):178-86. PubMed ID: 18155644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additivity of protein and nonprotein inhibitors of lung surfactant activity.
    Wang Z; Notter RH
    Am J Respir Crit Care Med; 1998 Jul; 158(1):28-35. PubMed ID: 9655703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity and inhibition resistance of a phospholipase-resistant synthetic surfactant in rat lungs.
    Wang Z; Chang Y; Schwan AL; Notter RH
    Am J Respir Cell Mol Biol; 2007 Oct; 37(4):387-94. PubMed ID: 17556674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary surfactant-associated protein A enhances the surface activity of lipid extract surfactant and reverses inhibition by blood proteins in vitro.
    Cockshutt AM; Weitz J; Possmayer F
    Biochemistry; 1990 Sep; 29(36):8424-9. PubMed ID: 2252903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.